Items where authors include "Tanser, F."

Article

Sharman Moser, S. orcid.org/0000-0002-9745-2016, Tanser, F., Siegelmann-Danieli, N. et al. (3 more authors) (2023) The reimbursement process in three national healthcare systems: variation in time to reimbursement of pembrolizumab for metastatic non-small cell lung cancer. Journal of Pharmaceutical Policy and Practice, 16 (1). 22. ISSN 2052-3211

Bell Gorrod, H. orcid.org/0000-0001-8054-8073, Fox, M.P., Boulle, A. et al. (5 more authors) (2020) The impact of delayed switch to second-line antiretroviral therapy on mortality, depending on failure time definition and CD4 count at failure. American Journal of Epidemiology, 189 (8). pp. 811-819. ISSN 0002-9262